CARL ZEISS MEDITEC ADR 1 (AFXA) — Cash Flow Quality Index
CARL ZEISS MEDITEC ADR 1 (AFXA) has a Cash Flow Quality Index of 2.78x as of September 2025. Operating cash flow of €144.16 Million exceeds net income of €51.81 Million, indicating high earnings quality where cash backs reported profits. Explore CARL ZEISS MEDITEC ADR 1 debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CARL ZEISS MEDITEC ADR 1 Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for CARL ZEISS MEDITEC ADR 1 across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of CARL ZEISS MEDITEC ADR 1.
Annual Cash Flow Quality Index for CARL ZEISS MEDITEC ADR 1 (2022–2025)
Year-by-year earnings quality comparison for CARL ZEISS MEDITEC ADR 1.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.49x | €209.86 Million | €141.21 Million | ▲ +7.4% |
| 2024 | 1.38x | €247.32 Million | €178.73 Million | ▲ +60.2% |
| 2023 | 0.86x | €250.86 Million | €290.40 Million | ▲ +34.9% |
| 2022 | 0.64x | €188.20 Million | €293.91 Million | — |